I-NIH Ukuqashwa Iziguli Ze-Hypothyroid for Study New
Usuku olujabulisayo lweziguli ze-thyroid, futhi elilinde isikhathi eside. I-US National Institutes of Health iye yamemezela ukuthi ukuhlolwa komtholampilo sekuqalile ngo-2012 eWalter Reed National Military Medical Centre, eBethesda, MD, ukutadisha izidakamizwa zemvelo ezithintekayo zemithi ye-thyroid versus levothyroxine, ekwelapheni kwe-hypothyroidism eyinhloko.
Ucwaningo olungenangqondo, oluqhubekayo - olwenziwa ngoMeyi ka-2014 - luzohlola ukuthi iziguli ze-hypothyroid ezitholakala emzimbeni wemvelo (lokho okubhekwa ngokuthi "ukukhishwa kwe-thyroid" noma i-DTE) kungase kube "nokunciphisa izimpawu, ukuthuthukiswa komsebenzi wokuqonda, nokwanda komqondo wokuphila / ikhwalithi yokuphila , "uma kuqhathaniswa ne-levothyroxine.
Isihloko esisemthethweni salolu cwaningo sithi "Ukuchazwa Kwesisindo Se-Thyroid Uma kuqhathaniswa ne- Levothyroxine ku-Treatment of Hypothyroidism : Isifundo Esingahleliwe, Esiyimpumputhe-Double, eyimpumputhe," futhi baqhamuka iziguli ze-thyroid njengabahlanganyeli bokufunda.
Ukufaneleka
Uyakwazi ukuhlanganyela kulolu cwaningo uma ungumuntu noma owesifazane, phakathi kweminyaka engu-18 no-65 ubudala. futhi ube se-levothyroxine ye-primary hypothyroidism okungenani izinyanga ezingu-6. (QAPHELA: Amalungu asebenzayo kuphela noma asetshentshe umhlalaphansi wezempi nabazuzi bawo afanelekile kulolu cwaningo.)Ukungabikho
Uzobekwa eceleni esifundweni uma unemibandela noma izinkinga ezilandelayo:- ukukhulelwa noma uhlelo lokukhulelwa ezinyangeni ezingu-12 ezizayo
- isifo senhliziyo , ikakhulukazi isifo somzimba we-coronary
- isifo se-chronic obstructive lung
- i-malabsorption disorder
- ukuhlinzwa kwamathumbu
- ukudlwengula okuphawulekayo noma ukungasebenzi kwesibindi
- ukuphazamiseka kwengcindezi
- umdlavuza we-thyroid ne-non-thyroid
- ingqondo engalawuleki
- ukusetshenziswa kwemithi ye-psychotropic
- ukusetshenziswa kwe-steroid
- ukusetshenziswa kwe-amiodarone
- i-chemotherapy yomdlavuza
- insimbi engeza ngaphezu kuka-325mg ngosuku
- ukusetshenziswa kwe-carafate / proton pump inhibitor
- ukusetshenziswa kwe-cholestyramine
Kungani lokhu Kuvivinyo Kubalulekile?
Leli cala libalulekile ngoba okokuqala emlandweni wamanje ukuthi ngiyazi ukuthi iqembu elibhekwa kwezokwelapha eliqashelwa ezweni lonke - kulokhu, i-US National Institutes of Health - lwenza ucwaningo oluphindaphindiwe oluphindwe kabili, ukuze luqhathaniswe izimpawu, umsebenzi wokuqonda, inhlalakahle, kanye nekhwalithi yokuphila ezigulini ze-hypothyroid emithini yemvelo ekhishwe imvelo, ngokuhambisana nevothyroxine ejwayelekile kakhulu.Leli cala libalulekile ngoba kukhona ukuphikisana okuqinile phakathi kwe-endocrinologists evamile ekunqumeni izidakamizwa zemvelo ezikhishwe emvelo, kodwa akusekelwe ocwaningweni, kodwa kunalokho, imibono yabo kanye nezintandokazi zabo. Abanye be-endocrinologists, eqinisweni, baye bathi ngisho nezidakamizwa zemvelo ye-thyroid ezifana ne-Armor zithathwa kuphela "nge-fringe" , naphezu kokuba imithi engaphezu kwezigidi ezimbili yalezi zidakamizwa ibhaliwe minyaka yonke e-United States yedwa, nokunye okuzungezile umhlaba.
Lesi silingo sibalulekile ngoba sidinga ucwaningo olubheke ngqo ekusetshenzisweni kwetrosi yemvelo. Ezinye izifundo, kuhlanganise nocwaningo lwesiDanishi ka - 2009 , zibonise ikhwalithi yokuthuthukiswa kokuphila kanye nokwengezwa kwe-synthetic T3 ekwenzeni izinto ze-T4 (levothyroxine), kodwa abanye odokotela baye bathi lezi zifundo azifanele uma ucabangela izidakamizwa zemvelo ezikhishwe emvelo (okuyinto ngokwemvelo iqukethe kokubili T3 no-T4 ) ngoba ziyimithi ehlukile.
Ukuze Uhlanganyele Esivivinyweni
Uma uhlangabezana neziqu futhi unesithakazelo sokubamba iqhaza kulolu cwaningo lwezomtholampilo, xhumana no-Mohamed Shakir, MD, 301-295-5165, mohamed.shakir@med.navy.mil noPatrick Clyde, MD, 301-295- 5165, patrick.clyde@med.navy.mil.I-Clinical Trials.gov inombolo yokukhomba yalolu cwaningo yi-NCT01739972.
Ungabona uhlu olugcwele lwe-ClinicalTrials.gov.